Showing results (381-390 of 459) with videos related to
Sort By:
Pageof 46
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 6, 2015
Transforming growth factor-β2 is sequestered in preterm human milk by chondroitin sulfate proteoglycansKopperuncholan Namachivayam, Hayley P Coffing, Nehru Viji Sankaranarayanan, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2004
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell countFelipe García, Elisa de Lazzari, Montserrat Plana, et al.AIDS (London, England)|May 4, 2005
Evolution of resistance mutations pattern in HIV-1-infected patients during intensification therapy with a boosted protease inhibitorJosé L Blanco, M Alejandra Biglia, Mireia Arnedo, et al.AIDS (London, England)|December 6, 2005
Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapyAnna Suy, Esteban Martínez, Oriol Coll, et al.The Journal of Antimicrobial Chemotherapy|May 5, 2022
Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia: a pilot studyJosé L Blanco, Jhon Rojas, Elisa de Lazzari, et al.The Journal of Antimicrobial Chemotherapy|July 22, 2021
Factors associated with the use and composition of two-drug regimens in a large single-centre HIV cohortElisa de Lazzari, Ana Gonzalez-Cordon, Alexy Inciarte, et al.Brain Structure & Function|May 12, 2012
Structural covariance of the neostriatum with regional gray matter volumesC Soriano-Mas, B J Harrison, J Pujol, et al.Enfermedades Infecciosas Y Microbiologia Clinica|February 11, 2005
[Advances in the diagnosis and treatment of hepatitis C virus infection in patients with and without HIV infection]Montse Laguno, José María Sánchez-Tapias, Javier Murillas, et al.The Journal of Antimicrobial Chemotherapy|June 25, 2025
48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trialElisa de Lazzari, Silvana Di Gregorio, Jhon Rojas, et al.Chemical Communications (Cambridge, England)|July 9, 2016
Trehalose-based Janus cyclooligosaccharides: the "Click" synthesis and DNA-directed assembly into pH-sensitive transfectious nanoparticlesJ L Jiménez Blanco, F Ortega-Caballero, L Blanco-Fernández, et al.Pageof 46